Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 SublineSergei Boichuk(Kazan State Medical University), Aigul Galembikova(Kazan State Medical University)DiagnosticsAugust 11, 202310.3390/diagnostics13162646Cited by 6SaveCiteExport RISWatch citationsRelated PapersInfigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells|Biomedicines|2022|35Design, Spectral Characteristics, Photostability, and Possibilities for Practical Application of BODIPY FL-Labeled Thioterpenoid|Bioengineering|2022|10